Level 2 of the validation pyramid for health apps is now activated in Belgium

09

Jul 2020

On 05 June 2020, mHealthBelgium announced the activation of Level 2 of the validation pyramid. This indicates that health applications that meet certain criteria can achieve Level 2. The National Institute for Health and Disability Insurance (INAMI) is working on the next step (level 3) - to introduce a structural framework for funding.

The mHealthBelgium platform, created in 2018, is managed by the Belgian Federation of the medical technology industry (beMedTech) and the Belgian Federation of Technology Companies (Agoria). The platform includes health applications according to a 3-step validation pyramid. The Federal Agency for Medicines and Health Products (FAMHP) is responsible for Level 1 (M1). Health application can be published on the platform with level 1 when it meets the basic requirements (recognition as a medical device ( CE marking) and compliance with European data protection regulations, as well as product notification in the FAMHP database).

Level 2 (M2) can be achieved if health application meets certain quality criteria in:

  • Identification and authentication of a user
  • Verification of the therapeutic relationship and informed consent
  • Interoperability
  • Data protection

After achieving M2 health application, developers will get access to more options, like risk assessment framework, test centers, a lot of useful information.

MoveUp Coach and Comunicare are the first health apps on mHealthBelgium, accomplished M2 validation. RemeCare, Well@Home, and AirView have already initiated the validation process.

BeMedTech, Agoria, and the National Institute for Health and Disability Insurance (INAMI) collaborated in recently created Telemedicine Working Group to accelerate the introduction of a structural framework for funding -next step (level 3).

See the full details here

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

21

Mar 2022

The NHS Insights Prioritisation Programme (NIPP) is commissioned by the NHS Accelerated Access Collaborative (AAC) and the National Institute for Health Research (NIHR). It is designed to accelerate the evaluation and implementation of innovation that supports post-pandemic ways of working, builds service resilience, and delivers benefits to patients. Fourteen projects have been funded and have now commenced activity that will be ongoing until March 2023.

Read more

17

Mar 2022

On February 21, 2022, it was announced by the Ministry of Health that the public consultation regarding the Draft Order amending the Common Package of Benefits of the National Health System (SNS) was open. The amendments and clarifications are related to the fields of in-vitro diagnostics, ENT, pulmonary and airways, e-health, neurology, dental care, radiology, and enteral nutrition.

Read more

15

Mar 2022

The Belgian Health Care Knowledge Center (KCE) initiated a study aimed at defining a clear and transparent procedure for the evaluation of digital health technologies in Belgium.

Read more

10

Mar 2022

In February 2022, the Finnish Coordinating Center for Health Technology Assessment announced the release of the seven accomplished rapid hospital assessments performed by the Helsinki, Tampere, and Oulu University Hospital. The accomplished rapid HTAs concern the diagnostic imaging, e-Health, endocrine, endoscopy, men’s health, neuromodulation technology groups.

Read more

03

Mar 2022

In February 2022, two more health apps were introduced in the Directory of digital health applications (DiGAs) at the Federal Office for Drugs and Medical Devices (BfArM) and thus became reimbursable. These apps can be prescribed by physicians and psychotherapists and will be reimbursed by health insurers. In total, thirty health apps are now available at the DiGA Directory.

Read more